About Champions Oncology
Champions Oncology is a publicly traded, technology-enabled research company (NASDAQ: CSBR) headquartered in Hackensack, New Jersey. It provides end-to-end oncology drug discovery and development services to pharmaceutical and biotechnology companies, primarily through its TumorGraft Technology Platform — a patient-derived xenograft (PDX) approach based on implanting human tumors in immune-deficient mice. The company also offers Lumin Bioinformatics, an oncology data-driven software platform, and operates a wholly owned therapeutic subsidiary called Corellia.
Company details
Funding
Total raised
$14M
Last stage
Public
Investors
Founders
David Sidransky
Johns Hopkins University oncologist who founded Champions Oncology (formerly Champions Biotechnology) in 2007.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.